Endocrine Journal

Papers
(The H4-Index of Endocrine Journal is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 202170
Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study56
Thyroid complications of SARS and coronavirus disease 2019 (COVID-19)44
Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults27
Anti-diabetic effects of astaxanthin on an STZ-induced diabetic model in rats26
Distinct clinical features and prognosis between persistent and temporary thyroid dysfunctions by immune-checkpoint inhibitors26
Hormonal trends in patients suffering from long COVID symptoms25
Investigation of pituitary functions after acute coronavirus disease 201922
Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells <i>via</i> the PI3K/AKT/mTOR pathway21
The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies19
Proposal of diagnostic criteria for IgG4-related thyroid disease18
Effects of resistance training using elastic bands on muscle strength with or without a leucine supplement for 48 weeks in elderly patients with type 2 diabetes16
Exosomes from mesenchymal stem cells expressing microribonucleic acid-125b inhibit the progression of diabetic nephropathy <i>via</i> the tumour necrosis factor receptor-associated factor 16
Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population16
Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in bloo16
Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia15
0.029429197311401